InvestorsObserver
×
News Home

Is 22nd Century Group Inc (XXII) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?

Monday, July 25, 2022 12:54 PM | InvestorsObserver Analysts

Mentioned in this article

Is 22nd Century Group Inc (XXII) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?

22nd Century Group Inc (XXII) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. XXII received an overall rating of 75, which means that it scores higher than 75 percent of all stocks. 22nd Century Group Inc also achieved a score of 97 in the Drug Manufacturers - Specialty & Generic industry, putting it above 97 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 133 out of the 148 industries.

Overall Score - 75
XXII has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on XXII!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With 22nd Century Group Inc Stock Today?

22nd Century Group Inc (XXII) stock is down -5.56% while the S&P 500 has gained 0.3% as of 12:45 PM on Monday, Jul 25. XXII is down -$0.11 from the previous closing price of $1.98 on volume of 571,345 shares. Over the past year the S&P 500 is lower by -10.15% while XXII is down -39.48%. XXII lost -$0.23 per share the over the last 12 months. Click Here to get the full Stock Report for 22nd Century Group Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App